Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Queensland Health
Deloitte
Federal Trade Commission
Argus Health
Chinese Patent Office
Cantor Fitzgerald
Baxter
Merck

Generated: July 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,781,571

« Back to Dashboard

Summary for Patent: 8,781,571
Title:Switch validation circuit and method
Abstract: A switch operated therapeutic agent delivery device is described. Embodiments of the operated therapeutic agent delivery device include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, and a switch integrity subcircuit which is used to detect a fault or a precursor to a fault.
Inventor(s): Lemke; John (Pleasanton, CA), Satre; Scot (Brentwood, CA), Chen; Corinna X. (Oakland, CA), Read; Brian W. (Brier, WA)
Assignee: Incline Therapeutics, Inc. (Redwood City, CA)
Application Number:13/249,975
Patent Claim Types:
see list of patent claims
Device; Delivery; Use;

Drugs Protected by US Patent 8,781,571

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
The Medicines Co IONSYS fentanyl hydrochloride SYSTEM;IONTOPHORESIS, TRANSDERMAL 021338-001 May 22, 2006 DISCN Yes No ➤ Sign Up ➤ Sign Up Y METHOD FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF FENTANYL HYDROCHLORIDE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,781,571

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,645,179 Self-test for analgesic product ➤ Sign Up
8,301,238 Two-part electrotransport device ➤ Sign Up
8,428,709 Current control for electrotransport drug delivery ➤ Sign Up
9,364,656 Method of storing an electrotransport drug delivery device ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
US Department of Justice
Boehringer Ingelheim
Covington
Healthtrust
McKinsey
Colorcon
UBS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.